ORPHAGEN PHARMACEUTICALS

orphagen-pharmaceuticals-logo

Orphagen Pharmaceuticals is a drug discovery company.

#SimilarOrganizations #People #Website #More

ORPHAGEN PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2001-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.orphagen.com

Total Employee:
11+

Status:
Active

Contact:
+1 (858) 481-6191

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium Yoast Plugins


Similar Organizations

addrenex-pharmaceuticals-logo

Addrenex Pharmaceuticals

Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.

felicitex-therapeutics-logo

Felicitex Therapeutics

Felicitex Therapeutics is a drug discovery company


Current Advisors List

gonul-velicelebi_image

Gonul Velicelebi Member of the Board of Directors @ Orphagen Pharmaceuticals
Board_member
2013-03-01

Official Site Inspections

http://www.orphagen.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K

  • Host name: apache2-zoo.pdx1-shared-a1-16.dreamhost.com
  • IP address: 75.119.205.255
  • Location: Brea United States
  • Latitude: 33.9339
  • Longitude: -117.8854
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 92821

Loading ...

More informations about "Orphagen Pharmaceuticals"

Orphagen Pharmaceuticals - Crunchbase Company โ€ฆ

Orphagen Pharmaceuticals is located in San Diego, California, United States. Who are Orphagen Pharmaceuticals 's competitors? Alternatives and possible competitors to Orphagen Pharmaceuticals may include Felicitex Therapeutics โ€ฆSee details»

Orphagen Pharmaceuticals - Scott Thacher

See details»

Orphagen Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Orphagen Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Orphagen Pharmaceuticals - LinkedIn

Orphagen Pharmaceuticals Biotechnology San Diego, CA 761 followers Breakthrough therapies for inflammatory disease and oncologySee details»

ORPHAGEN PHARMACEUTICALS - VentureRadar

Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear receptor family. We have proprietary leads for โ€ฆSee details»

Orphagen Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Orphagen Pharmaceuticals is a pharmaceutical company focused on the discovery and development of small molecule therapies for cancer and inflammatory diseases. The company โ€ฆSee details»

Orphagen Pharmaceuticals - PitchBook

Orphagen Pharmaceuticals General Information Description. Developer of small molecule drugs designed to treat certain orphan nuclear receptors. The company's drugs treat psoriasis and โ€ฆSee details»

Orphagen Pharmaceuticals Company Profile - Office Locations

Orphagen Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for precision oncology and autoimmune disease. It is โ€ฆSee details»

Our Science - Orphagen Pharmaceuticals

Orphagen believes strongly in partnerships and collaborations to accelerate our path to discovery, clinical development and commercialization. We have attracted significant partners and โ€ฆSee details»

Orphagen CEO Scott Thacher, Ph.D. + Director of Chemistry Ruo โ€ฆ

Jul 12, 2013 CEO and Director, Orphagen Pharmaceuticals Scott Thacher founded Orphagen in 2001. He has 30 years of experience in life sciences research and pharmaceutical R&D and โ€ฆSee details»

Orphagen Pharmaceuticals Presents Data on Downstream Targets โ€ฆ

Jun 11, 2022 Orphagen CEO, Scott Thacher, Ph.D., said, โ€œThis is a satisfying success story for Orphagenโ€™s corporate strategy to find first-in-class small molecules for unexplored nuclear โ€ฆSee details»

Home - Orphagen

Orphagen is specialized in planning and executing strategies to support entry of orphan drugs in Greek & Cypriot markets, in compliance with the local & international ethics and regulations. โ€ฆSee details»

Pipeline - small molecules to several orphan nuclear receptors

Orphagen successfully partnered its first program for ROR-gamma antagonists with a mid-sized pharmaceutical company ahead of all competitors in the field. Funding from its partnerships โ€ฆSee details»

Orphagen Pharmaceuticals Presents Preclinical Efficacy Data at โ€ฆ

Apr 8, 2022 Release Summary. Orphagen Presents Preclinical Efficacy Data at AACR 2022 on OR-449, a First-in-Class SF-1 Inhibitor, for the Treatment of Leydig Cell TumorsSee details»

Orphagen Pharmaceuticals Receives Rare Pediatric Disease

Jan 17, 2023 Orphagen successfully partnered its first program for ROR-gamma antagonists with a mid-size pharmaceutical company ahead of all competitors in the field. Funding from its โ€ฆSee details»

Orphagen Pharmaceuticals Presents Preclinical Efficacy Data at โ€ฆ

SAN DIEGO, April 8, 2022 โ€” Orphagen Pharmaceuticals Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or โ€ฆSee details»

Orphagenix - Crunchbase Company Profile & Funding

OrphageniX is a biotechnology company that utilizes proprietary single stranded oligonucleotides to treat orphan diseases.See details»

News - Orphagen Pharmaceuticals

Oct 15, 2021 Orphagen Pharmaceuticals, a preclinical stage biopharmaceutical company focused on discovering and developing first-in-class therapeutics for cancer and inflammatory โ€ฆSee details»

ORPHAGEN PHARMACEUTICALS TO PRESENT PRECLINICAL DATA โ€ฆ

May 5, 2021 Orphagen Pharmaceuticals, an early-stage biopharmaceutical company focused on developing and commercializing novel therapies for cancer and other serious diseases with โ€ฆSee details»

linkstock.net © 2022. All rights reserved